Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 7, 2014; 20(13): 3640-3648
Published online Apr 7, 2014. doi: 10.3748/wjg.v20.i13.3640
Published online Apr 7, 2014. doi: 10.3748/wjg.v20.i13.3640
Table 4 Five-year overall survival by T stage subgroups and total number of examined lymph nodes
| Variables | Number of examined nodes (n) | χ2 | P value | |||
| 1-3 | 4-10 | 11-15 | ≥ 16 | |||
| Depth of invasion | ||||||
| T1 | 60.0% | 91.7% | - | 92.3% | 4.598 | 0.204 |
| T2 | 58.3% | 68.2% | 84.0% | 91.4% | 9.668 | 0.022 |
| T3 | 50.0% | 63.3% | 81.8% | 91.7% | 8.738 | 0.033 |
| T4 | 35.1% | 48.6% | 62.5% | 78.7% | 31.487 | < 0.001 |
| Total | 43.3% | 56.6% | 71.8% | 84.3% | 51.837 | < 0.001 |
- Citation: Jiao XG, Deng JY, Zhang RP, Wu LL, Wang L, Liu HG, Hao XS, Liang H. Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. World J Gastroenterol 2014; 20(13): 3640-3648
- URL: https://www.wjgnet.com/1007-9327/full/v20/i13/3640.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i13.3640